Other Products

We also have several other products in our portfolio which do not fall into our critical care or cancer franchises. These provide us with additional revenue streams or development opportunities that are beneficial to our business.

For more information on any of these products please click on the product name.

Products


TECHNOLOGY USES STATUS PARTNER MARKET
CoVaccine HT™
Proprietary adjuvant Enhances B-cell (antibody) responses in prophylactic and therapeutic vaccines Used in the Angiotensin Therapeutic Vaccine; under evaluation by several pharmaceutical companies
 Looking for other partners interested in licensing the adjuvant N/A
BSE Diagnostic Test
Transmissible
Spongiform Encephalopathy (TSE) Diagnostic Test
 Detection of Bovine Spongiform Encephalopathy (BSE) in carcasses Intellectual property out-licensed to Enfer Scientific Ltd. Enfer test kit approved in EU, US and Japan. Marketed by Enfer Scientific Ltd (Ireland); Enfer licensed to Abbott Laboratories Inc (RoW) Global royalty potential to Protherics of up to £10m

Research and Development

TECHNOLOGY USES STATUS PARTNER MARKET
Angiotensin Therapeutic
Vaccine
Therapeutic peptide; protein conjugate vaccine Hypertension Phase 2a study with new formulation planned for H1 2008 No partner
 Global market estimated at ~$30bn

* Based on Protherics estimates